What is the current Active B12 Test market size?

The Active B12 Test market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Active B12 Test market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Active B12 Test market?

Increasing demand for diagnostic tests and rising awareness of vitamin B12 deficiency drive the market.

What are the challenges faced by the Active B12 Test market?

Limited awareness and high costs of tests are major challenges in the Active B12 Test market.

Which regions are the leaders in the Active B12 Test market?

North America and Europe are the leading regions in the Active B12 Test market.

Who are the top companies in the Active B12 Test market?

Top companies include Abbott, Siemens, and Roche, which offer a range of diagnostic tests.

What are the future opportunities in the Active B12 Test market?

Emerging markets and technological advancements offer future opportunities for the Active B12 Test market.

How does technology impact the Active B12 Test market?

Advances in technology improve test accuracy and efficiency, driving the Active B12 Test market growth.

What is the regulatory landscape of the Active B12 Test market?

The market is regulated by authorities such as FDA and CE, ensuring safety and efficacy of tests.

What is the future outlook of the Active B12 Test market?

The future outlook is positive, with increasing demand for diagnostic tests and growing awareness.

Active B12 Test Value Chain Analysis & Forecast Outlook 2033

Active B12 Test by Application (Folate Deficiency Anemia, Pernicious Anemia, Macrocytic Anemia, Others), by Types (ELISA Assay, Enzyme Immunoassay, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $170.8 million

CAGR: 4.1%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $170.8 million

CAGR: 4.1%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Active B12 Test Market Overview

The Active B12 Test market refers to the diagnostic testing for active vitamin B12, a crucial nutrient for the production of red blood cells. As the Active B12 Test market size is estimated to be around $1.4 billion in 2025, the growth outlook for this market is promising, driven by the increasing prevalence of vitamin B12 deficiency and the rising demand for accurate diagnostic tests. The market forecast indicates a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period of 2026-2033, driven by industry expansion and advancements in technology. The scope of this market encompasses various types of tests, including enzyme-linked immunosorbent assay (ELISA) and chemiluminescent microparticle immunoassay (CMIA), and applications in hospitals, clinics, and research institutions.

Loading chart…

The Active B12 Test market is driven by key forces such as technology shifts, with the increasing adoption of automated testing systems, regulations, with the implementation of stricter guidelines for diagnostic testing, and consumer behavior, with the growing awareness of the importance of vitamin B12 deficiency diagnosis. The largest region for this market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing demand for diagnostic tests in emerging countries. The market is expected to be shaped by the competitive intensity of key players, with companies such as Abbott and Roche dominating the market. As the market continues to evolve, it is essential for strategic planners and business development teams to stay informed about the latest trends and developments in the Active B12 Test market.

Report Overview

Report Attribute	Details
Market size value in 2025	170.80 million
Revenue forecast in 2033	297.88 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Axis-Shield Diagnostics; Abbott; Siemens; DiaSorin; Roche; LifeSpan BioSciences; Demeditec Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Active B12 Test market is poised for significant growth, driven by increasing awareness of vitamin B12 deficiency and the importance of accurate diagnosis. Key factors influencing the Active B12 Test market size and growth forecast include:

Growth Drivers2 items

Rising demand for precise diagnostic tests due to the growing prevalence of vitamin B12 deficiency, particularly among the elderly and vegan populations

Advancements in testing technologies, such as liquid chromatography-mass spectrometry, enabling more accurate and efficient Active B12 Test results

Restraints2 items

High costs associated with Active B12 Test kits and equipment, limiting adoption in resource-constrained settings

Stringent regulatory requirements and varying reimbursement policies across different regions, affecting the Active B12 Test market growth forecast

Opportunities2 items

Expanding applications of Active B12 Test in personalized medicine and preventive care, offering opportunities for market expansion

Growing demand from emerging economies, driven by increasing healthcare expenditure and improving access to diagnostic facilities

Challenges2 items

Intense competition among Active B12 Test manufacturers, leading to pricing pressures and affecting profit margins

Need for ongoing research and development to stay ahead of technological advancements and evolving consumer needs in the Active B12 Test market

Market Segmentation

Loading chart…

The Application segment of the Active B12 Test market refers to the various uses of Active B12 tests in different fields. This includes clinical applications, such as diagnosing vitamin B12 deficiency, and research applications, where Active B12 tests are used to study the role of vitamin B12 in various diseases. Understanding the Active B12 Test segmentation by application is crucial for manufacturers to tailor their products to specific markets, ultimately contributing to the overall Active B12 Test market size. The application segment is a key component of the market taxonomy, influencing the development of new products and services.

The Types segment of the Active B12 Test market encompasses various subtypes, including [object Object] and [object Object]. Each subtype has its own unique characteristics, advantages, and limitations. For instance, some types of Active B12 tests may be more sensitive or specific than others, making them more suitable for certain applications. Analyzing the Active B12 Test market by type is essential for understanding the competitive landscape and identifying opportunities for growth. By examining the different types of Active B12 tests, manufacturers can optimize their product offerings, driving innovation and expansion in the Active B12 Test market.

Active B12 Test Segmentation Breakdown9 items

Application

Folate Deficiency Anemia

Pernicious Anemia

Macrocytic Anemia

Others

Types

ELISA Assay

Enzyme Immunoassay

Others

Regional Insights

Loading chart…

The Active B12 Test market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market. This region is also anticipated to be the fastest-growing, driven by key factors such as increasing adoption of Active B12 tests, government policies supporting healthcare infrastructure development, and significant investments in research and development.

In North America, key drivers include a mature ecosystem, high demographics awareness, and established infrastructure. Europe is driven by adoption of advanced diagnostic technologies, favorable policies, and a strong ecosystem. Latin America and Middle East & Africa are expected to experience growth due to increasing investments in healthcare, improving infrastructure, and rising demographics demands.

Regional Forecast4 items

Asia Pacific: increasing adoption and government support

North America: mature ecosystem and high demographics awareness

Europe: adoption of advanced diagnostic technologies and favorable policies

Latin America and Middle East & Africa: increasing investments in healthcare and improving infrastructure

Competitive Landscape

The Active B12 Test market is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Active B12 Test competitive landscape is characterized by high competition, with companies focusing on differentiation through innovative products and services. Global players are expanding their presence through strategic partnerships and acquisitions, while local companies are leveraging their regional strengths to compete.

Companies in the Active B12 Test market are adopting various strategies to differentiate themselves and gain a competitive edge. Common strategies include M&A, partnerships, product launches, expansion, R&D, and localization. However, companies face challenges such as margin pressure, compliance costs, and commoditization, which can erode their competitive advantage. To address these challenges, companies are focusing on technology, service model, channel strength, customization, and cost advantages to differentiate themselves. The following companies are implementing these strategies:

Axis-Shield Diagnostics: regional expansion

Abbott: premium pricing

Siemens: innovation pipeline

DiaSorin: OEM tie-ups

Roche: local manufacturing

LifeSpan BioSciences: vertical integration

Key Active B12 Test Companies7 items

Axis-Shield Diagnostics

Abbott

Siemens

DiaSorin

Roche

LifeSpan BioSciences

Demeditec Diagnostics

Market Ecosystem

The Active B12 Test ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly categorized into three stages: upstream, midstream, and downstream, with value created and captured at each stage. The Active B12 Test ecosystem is shaped by the interactions and interdependencies among these participants, influencing the overall value chain analysis.

Raw material/component suppliers — provide essential components

OEMs / manufacturers — design and produce Active B12 Test kits

Technology providers — develop and license underlying technologies

Distributors / channel partners — facilitate product distribution and sales

Service providers / after-sales — offer maintenance, support, and training services

End users / buyers — purchase and utilize Active B12 Test products

Regulators/standards bodies — establish and enforce regulatory standards

In the Active B12 Test ecosystem, control points are primarily held by regulators and standards bodies, as they influence adoption through approvals and standards. Dependency risks arise from input constraints, such as the availability of raw materials, and regulatory approvals. Switching costs and partnerships also play a crucial role, as companies may face significant costs when changing suppliers or partners. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and market conditions, highlighting the need for a nuanced understanding of the Active B12 Test ecosystem.

Recent Industry Insights

The Active B12 Test market has witnessed significant developments over the last 12-18 months, shaping the Active B12 Test industry trends. Notably, there have been strategic partnerships between leading diagnostic companies and research institutions to enhance the accuracy and accessibility of Active B12 tests. Furthermore, mergers and acquisitions have led to the consolidation of market players, resulting in enhanced product portfolios and expanded distribution networks.

Recent product launches have focused on point-of-care testing solutions, offering healthcare providers rapid and reliable diagnostic tools. Regulatory changes have also played a crucial role, with updated guidelines emphasizing the importance of accurate vitamin B12 deficiency diagnosis and treatment. Additionally, a shift in consumer trends towards preventive healthcare has driven demand for Active B12 tests, with several companies securing funding rounds to support the development and commercialization of innovative testing solutions.

Analyst Overview

As the Lead Analyst for this study, I conclude that the Active B12 Test market exhibits moderate attractiveness, driven by growing demand for diagnostic tests. The competitive intensity is relatively high, with key players investing in research and development to improve test accuracy and efficiency. The long-term Active B12 Test market outlook appears promising, with opportunities for innovation in point-of-care testing and personalized medicine. However, the demand-supply balance may be affected by regulatory changes and fluctuations in raw material prices. Key risk factors include intense competition, rapid technological advancements, and evolving customer needs, which may impact market dynamics and require strategic adaptations from industry players.

12 items

1. Executive Summary

2. Active B12 Test Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Active B12 Test Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Active B12 Test Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Active B12 Test Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Active B12 Test Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Active B12 Test Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Active B12 Test Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Active B12 Test Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Active B12 Test Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Active B12 Test Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Active B12 Test Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Active B12 Test Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Active B12 Test Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Active B12 Test Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Active B12 Test Market Competition by Key Manufacturers

9.1. Global Active B12 Test Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Active B12 Test: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Axis-Shield Diagnostics

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Abbott

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Siemens

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. DiaSorin

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Roche

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. LifeSpan BioSciences

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Demeditec Diagnostics

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Active B12 Test Market

Figure 4: Global Active B12 Test Market: Drivers

Figure 5: Global Active B12 Test Market: Challenges

Figure 6: Global Active B12 Test Market: Trends

Figure 7: Global Active B12 Test Market: Opportunity

Figure 8: Global Active B12 Test Market: Restraint

Figure 9: Global Active B12 Test Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Active B12 Test Market Value (USD Million) By Region

Figure 19: Global Active B12 Test Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Active B12 Test Market Value (USD Million) By Region

Figure 27: Global Active B12 Test Market Share (%) By: Regions (2032)

Figure 28: Global Active B12 Test Market Volume (K) By Region

Figure 29: Global Active B12 Test Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Active B12 Test Market Value (USD Million) By Region

Figure 37: Global Active B12 Test Market Share (%) By: Regions (2032)

Figure 38: Global Active B12 Test Market Volume (K) By Region

Figure 39: Global Active B12 Test Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Active B12 Test Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Active B12 Test Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Active B12 Test Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Active B12 Test Market Value (USD Million) By Region

Table 14: Global Active B12 Test Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Active B12 Test Market Volume (K) By Region

Table 31: Global Active B12 Test Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Active B12 Test Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Active B12 Test Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Active B12 Test Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Axis-Shield Diagnostics Basic Information And Sales Area

Table 52: Axis-Shield Diagnostics. Products Portfolio

Table 53: Abbott Basic Information And Sales Area

Table 54: Abbott. Products Portfolio

Table 55: Siemens Basic Information And Sales Area

Table 56: Siemens. Products Portfolio

Table 57: DiaSorin Basic Information And Sales Area

Table 58: DiaSorin. Products Portfolio

Table 59: Roche Basic Information And Sales Area

Table 60: Roche. Products Portfolio

Table 61: LifeSpan BioSciences Basic Information And Sales Area

Table 62: LifeSpan BioSciences. Products Portfolio

Table 63: Demeditec Diagnostics Basic Information And Sales Area

Table 64: Demeditec Diagnostics. Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Active B12 Test Market Value (USD Million) By Region

Table 74: Global Active B12 Test Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Application

Table 77: North America Market Value (USD Million) (2025-2032) By Types

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Application

Table 80: Europe Market Value (USD Million) (2025-2032) By Types

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Application

Table 86: South America Market Value (USD Million) (2025-2032) By Types

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 90: Global Active B12 Test Market Volume (K) By Region

Table 91: Global Active B12 Test Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Application

Table 94: North America Market Volume (K) (2025-2032) By Types

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Types

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Types

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Active B12 Test Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	170.80 million
Revenue forecast in 2033	297.88 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Axis-Shield Diagnostics; Abbott; Siemens; DiaSorin; Roche; LifeSpan BioSciences; Demeditec Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for precise diagnostic tests due to the growing prevalence of vitamin B12 deficiency, particularly among the elderly and vegan populations

Advancements in testing technologies, such as liquid chromatography-mass spectrometry, enabling more accurate and efficient Active B12 Test results

Restraints2 items

High costs associated with Active B12 Test kits and equipment, limiting adoption in resource-constrained settings

Stringent regulatory requirements and varying reimbursement policies across different regions, affecting the Active B12 Test market growth forecast

Opportunities2 items

Expanding applications of Active B12 Test in personalized medicine and preventive care, offering opportunities for market expansion

Growing demand from emerging economies, driven by increasing healthcare expenditure and improving access to diagnostic facilities

Challenges2 items

Intense competition among Active B12 Test manufacturers, leading to pricing pressures and affecting profit margins

Need for ongoing research and development to stay ahead of technological advancements and evolving consumer needs in the Active B12 Test market

Market Segmentation

Loading chart…

Active B12 Test Segmentation Breakdown9 items

Application

Folate Deficiency Anemia

Pernicious Anemia

Macrocytic Anemia

Others

Types

ELISA Assay

Enzyme Immunoassay

Others

Regional Insights

Loading chart…

Regional Forecast4 items

Asia Pacific: increasing adoption and government support

North America: mature ecosystem and high demographics awareness

Europe: adoption of advanced diagnostic technologies and favorable policies

Latin America and Middle East & Africa: increasing investments in healthcare and improving infrastructure

Competitive Landscape

Axis-Shield Diagnostics: regional expansion

Abbott: premium pricing

Siemens: innovation pipeline

DiaSorin: OEM tie-ups

Roche: local manufacturing

LifeSpan BioSciences: vertical integration

Key Active B12 Test Companies7 items

Axis-Shield Diagnostics

Abbott

Siemens

DiaSorin

Roche

LifeSpan BioSciences

Demeditec Diagnostics

Market Ecosystem

Raw material/component suppliers — provide essential components

OEMs / manufacturers — design and produce Active B12 Test kits

Technology providers — develop and license underlying technologies

Distributors / channel partners — facilitate product distribution and sales

Service providers / after-sales — offer maintenance, support, and training services

End users / buyers — purchase and utilize Active B12 Test products

Regulators/standards bodies — establish and enforce regulatory standards

Recent Industry Insights

Analyst Overview

Table of Contents